Free US stock education platform offering courses, webinars, and one-on-one coaching to help investors develop winning strategies. Our educational content ranges from basic investing principles to advanced technical analysis techniques used by professionals.
As of 2026-04-08, Keros Therapeutics Inc. (KROS) is trading at a current price of $12.5, marking a 2.12% gain on the day. This analysis examines key technical levels, recent market context, and potential future scenarios for the biotech stock, with no recent earnings data available for the company as of this publication. KROS has seen relatively range-bound trading in recent weeks, with price action largely tied to broader biotech sector flows rather than company-specific news. Key takeaways for
Is Keros Therapeutics (KROS) Stock heavily shorted | Price at $12.50, Up 2.12% - Scalping
KROS - Stock Analysis
3500 Comments
1840 Likes
1
Socheata
Elite Member
2 hours ago
Clear explanations of market dynamics make this very readable.
👍 233
Reply
2
Izariah
Daily Reader
5 hours ago
This is exactly the info I needed before making a move.
👍 49
Reply
3
Forace
Elite Member
1 day ago
I feel like applauding for a week straight. 👏
👍 107
Reply
4
Rubyn
Active Contributor
1 day ago
This would’ve been perfect a few hours ago.
👍 63
Reply
5
Tayhlor
Engaged Reader
2 days ago
Balanced approach between optimism and caution is appreciated.
👍 256
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.